Wintermar Offshore (WINS:JK) Reports 9M2025 Results 
Star Plus Legend (6683.HK) Becomes a Strategic Shareholder of Galaxy 
Geekvape SOUL II Wins 2025 MUSE Gold Award – A Testament to Strength and Innovation 
AI Pets Platform FurGPT Prepares to List FGPT Token on Binance Exchange and Aster DEX 
Beyond Music, Beyond Worlds – X:THELABEL Rewrites the Rules of Virtual K-Pop ECMOHO Limited Launches B2B Supply & Marketing Platform to Facilitate over 100 million RMB GMV
SHANGHAI, China, July 28, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the…
eureKARE launches inaugural eureKAWARDS to support European synthetic biology innovation
eureKARE launches inaugural eureKAWARDS to support European synthetic biology innovation Opportunity to showcase ground-breaking ideas,…
Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF)
Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF) – Angelini Pharma…
Idorsia launches the offering of convertible bonds to fund the development of the company into a leading biopharmaceutical company
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR…
HUTCHMED and AstraZeneca Initiate Phase II Trial of ORPATHYS® in Patients with MET Amplified Gastric Cancer
— Follows multiple Phase II studies of ORPATHYS® in Asia including VIKTORY, which reported an 50%…
Mubadala Invests in Global Biosimulation Leader Certara
PRINCETON, N.J., July 27, 2021 (GLOBE NEWSWIRE) — Certara (NASDAQ: CERT), a global leader in biosimulation,…
AzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Shares
BOCA RATON, Fla., July 27, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx”…
Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference
DURHAM, N.C., July 27, 2021 (GLOBE NEWSWIRE) — Senior management of Bioventus Inc. (Nasdaq: BVS)…
Clearside Biomedical to Report Second Quarter 2021 Financial Results and Provide Corporate Update on Tuesday, August 10, 2021
ALPHARETTA, Ga., July 27, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated…
SOPHiA GENETICS Announces Closing of $234 Million Initial Public Offering and $20 Million Private Placement
BOSTON and LAUSANNE, Switzerland, July 27, 2021 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH),…
Zealand Pharma A/S – Final Transactions Under Share Repurchase Program
Company announcement – No. 47 / 2021 Zealand Pharma A/S – Final Transactions Under Share…
NexImmune to Announce Second Quarter 2021 Financial Results and Provide Corporate Update on August 9, 2021
GAITHERSBURG, Md., July 27, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company…
XcelPlus International completes $1 million seed funding round, adds Ford Seeman to Board of Directors
Reno, NV, July 27, 2021 (GLOBE NEWSWIRE) — XcelPlus International Inc. (OTC Pink: XLPI) announced…
Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017
Bone Therapeutics to focus in future on the development of its MSC cell and gene…
Spectral Medical Inc. Closes $10 Million Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…
Sunshine Biopharma Opens Twitter Account For Increased Shareholder Engagement
MONTREAL, July 27, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
BioStem Technologies, Inc., Announces the Engagement of Biologics Consulting To Support FDA Strategies and Submissions.
Pompano Beach, Fl., July 27, 2021 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC PINK: BSEM)…
Medicenna Announces That Initiation of MDNA11 Phase 1/2 Study is on Track; Update to be Provided at the PropThink Digital Conference
– Phase 1/2 ABILITY Study is designed to evaluate MDNA11, a potentially best-in-class IL-2 Superkine,…
Allogene Therapeutics to Report Second Quarter Financial Results on August 4, 2021
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield” to Discuss Concussion Treatments
IRVINE, CA, July 27, 2021 (GLOBE NEWSWIRE) — Odyssey Group International, Inc. (OTCQB:ODYY) (the “Company”…